Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT06190899 · RECRUITING

Trial details

NCT number: NCT06190899
Sponsor: Celcuity Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

mCRPC (Metastatic Castration-resistant Prostate Cancer)Genital Diseases, Male Urogenital Diseases, Male Prostatic Disease Prostatic Neoplasms, Castration-Resistant Prostate Cancer

Start date: 2024-01-01
Primary completion: 2028-01-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.